Consortium comprising SK, IDT, and Vaxxas introduced a high-density microarray patch (HD-MAP) for vaccines in Europe, aiming to enhance vaccine efficacy and availability. They are focused on developing HD-MAP vaccines with high immunogenicity for both seasonal and pandemic influenza. The initiative is set to address pressing immunization challenges by capitalizing on innovative technology.